Professor Elisabeth Vandenberghe

• Vandenberghe E, Pearce R, Taghipour G, Fouillard L, Goldstone AH, Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry., 1997Journal Article, 1997
• Vandenberghe EA, Goldstone AH, Autologous stem cell transplants in lymphomas., 1996Journal Article, 1996
• Vandenberghe E, Mantle cell lymphoma., 1994Journal Article, 1994
• Vandenberghe E, Van Hove J, Brock P, Schmidt P, Delabie J, Casteels-Van Daele M, Cassiman JJ, Vanderschueren-Lodeweyckx M, Van den Berghe H, Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome., 1993Journal Article, 1993
• Liesner RJ, Vandenberghe EA, Davies SC, Analgesics in sickle-cell disease., 1993Journal Article, 1993
• Criel A, Billiet J, Vandenberghe E, van den Berghe H, Louwagie A, Hidajat M, Vanhoof A, Leukaemic intermediate lymphocytic lymphomas: analysis of twelve cases diagnosed by morphology., 1992Journal Article, 1992
• Vandenberghe E, De Wolf Peeters C, Wlodarska I, Stul M, Louwagie A, Verhoef G, Thomas J, Criel A, Cassiman JJ, Mecucci C, Chromosome 11q rearrangements in B non Hodgkin's lymphoma., 1992Journal Article, 1992
• Cuneo A, Mecucci C, Kerim S, Vandenberghe E, Dal Cin P, Van Orshoven A, Rodhain J, Bosly A, Michaux JL, Martiat P, Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients., 1989Journal Article, 1989
• Cuneo A, Kerim S, Vandenberghe E, Van Orshoven A, Rodhain J, Bosly A, Zachee P, Louwagie A, Michaux JL, Dal Cin P, Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement., 1989Journal Article, 1989
• Vandenberghe E, Staines A, Breatnach F, O'Meara A, Recent experience with intensive combination chemotherapy for treatment of childhood acute lymphoblastic leukaemia., 1989Journal Article, 1989
• Zinzani PL, d'Amore F, Bombardieri E, Brammer C, Codina JG, Illidge T, Jurczak W, Linkesch W, Morschhauser F, Vandenberghe E, Van Hoof A, Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop., 2008Journal Article, 2008
• Hayden PJ, Keogh F, Ni Conghaile M, Carroll M, Crowley M, Fitzsimon N, Gardiner N, Vandenberghe E, O'Riordan J, McCann SR, A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase., 2004Journal Article, 2004
• Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N, Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries., 2003Journal Article, 2003
• Marks DI, Lush R, Cavenagh J, Milligan DW, Schey S, Parker A, Clark FJ, Hunt L, Yin J, Fuller S, Vandenberghe E, Marsh J, Littlewood T, Smith GM, Culligan D, Hunter A, Chopra R, Davies A, Towlson K, Williams CD, The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation., 2002Journal Article, 2002
• Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA, Alcock HE, Baird M, Lorigan PC, Vandenberghe EA, Hancock BW, Hammond DW, Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization., 2002Journal Article, 2002
• Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA, Barker HF, Posttransplant immune-mediated hemolysis., 2002Journal Article, 2002
• Wlodarska I, Mecucci C, Vandenberghe E, De Wolf-Peeters C, Thomas J, Hilliker C, Schoenmakers E, Stul M, Marynen P, Cassiman JJ, dup(12)(q13----qter) in two t(14;18)-negative follicular B-non-Hodgkin's lymphomas., 1992Journal Article, 1992
• Cuneo A, Michaux JL, Ferrant A, Van Hove L, Bosly A, Stul M, Dal Cin P, Vandenberghe E, Cassiman JJ, Negrini M, Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers., 1992Journal Article, 1992
• Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C, Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype., 1992Journal Article, 1992
• Vandenberghe E, Baens M, Stul M, Bosly A, Cassiman JJ, Mecucci C, Van den Berghe H, Alteration of N-ras mutation in a patient with AML M4 and trilineage myelodysplasia., 1991Journal Article, 1991
• Vandenberghe E, van den Oord J, Mecucci C, Van den Berghe H, De Wolf-Peeters C, B-cell non-Hodgkin's lymphomas of follicle mantle lineage: part of a biological spectrum?, 1991Journal Article, 1991
• Vandenberghe E, Martiat P, Baens M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, Van den Berghe H, Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome., 1991Journal Article, 1991
• Vandenberghe E, de Wolf-Peeters C, Delabie J, Thomas J, Michaux JL, Noël H, Mecucci C, Van Den Berghe H, Cytogenetic characterization of three cases of unusual B-cell non-Hodgkin's lymphoma., 1991Journal Article, 1991
• Delabie J, De Wolf-Peeters C, De Vos R, Vandenberghe E, Kennes K, De Jonge I, Desmet V, True histiocytic neoplasm of Langerhans' cell type., 1991Journal Article, 1991
• Vandenberghe E, De Wolf-Peeters C, van den Oord J, Wlodarska I, Delabie J, Stul M, Thomas J, Michaux JL, Mecucci C, Cassiman JJ, Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage., 1991Journal Article, 1991
• Cuneo A, Gretel Carli M, Piva N, Fagioli F, Vandenberghe E, Dal Cin P, Castoldi G, Van Den Berghe H, Clinicopathological evolution and multilineage involvement in erythroleukemia: report of a case., 1991Journal Article, 1991
• Busschots AM, Mecucci C, Stul M, Vandenberghe E, Michaux JL, Noel H, Cassiman JJ, Van Den Berghe H, Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL., 1991Journal Article, 1991
• Vandenberghe EA, Mecucci C, Delannoy A, Van den Berghe H, Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome., 1990Journal Article, 1990
• Kerim S, Stul M, Mecucci C, Vandenberghe E, Cuneo A, Dal Cin P, Michaux JL, Louwagie A, Cassiman JJ, Van den Berghe H, Rearrangement of immunoglobulin and TCR genes in lymphoid blast crisis of Ph+ chronic myeloid leukaemia., 1990Journal Article, 1990
• Kerim S, Mecucci C, Cuneo A, Vandenberghe E, Louwagie A, Stul M, Michaux JL, Van Den Berghe H, 5q- anomaly in lymphoid disorders., 1990Journal Article, 1990
• Wilson GA, Vandenberghe EA, Pollitt RC, Rees DC, Goodeve AC, Peake IR, Reilly JT, Are aberrant BCR--ABL transcripts more common than previously thought?, 2000Journal Article, 2000
• Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP, Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia., 2000Journal Article, 2000
• Abu-Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, Vandenberghe EA, Winship PR, Reilly JT, FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group., 2000Journal Article, 2000
• Gari M, Goodeve A, Wilson G, Winship P, Langabeer S, Linch D, Vandenberghe E, Peake I, Reilly J, c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia., 1999Journal Article, 1999
• Vandenberghe E, De Wolf-Peeters C, Vaughan Hudson G, Vaughan Hudson B, Pittaluga S, Anderson L, Linch DC, The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group., 1997Journal Article, 1997
• Sampson FC, Beard SM, Scott F, Vandenberghe E, Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma., 2001Journal Article, 2001
• Wilson G, Frost L, Goodeve A, Vandenberghe E, Peake I, Reilly J, BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia., 1997Journal Article, 1997
• Richardson SE, Khan I, Rawstron A, Sudak J, Edwards N, Verfuerth S, Fielding AK, Goldstone A, Kottaridis P, Morris E, Benjamin R, Peggs KS, Thomson KJ, Vandenberghe E, Mackinnon S, Chakraverty R, Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia., 2013Journal Article, 2013
• Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E, Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion., 2011Journal Article, 2011
• Fortune A, O'Leary H, Gilmore R, Chadwick N, Brennan L, Ní Chonghaile M, McCann SR, Browne PV, Conneally E, Vandenberghe E, T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcome., 2010Journal Article, 2010
• McElligott AM, Maginn EN, Greene LM, McGuckin S, Hayat A, Browne PV, Butini S, Campiani G, Catherwood MA, Vandenberghe E, Williams DC, Zisterer DM, Lawler M, The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia., 2009Journal Article, 2009
• Smyth L, Browne PV, Conneally E, Flynn C, Hayden P, Jeffers M, O'Brien D, Quinn F, Kelly J, Perera M, Crotty GM, Leahy M, Hennessy B, Jackson F, Ryan M, Vandenberghe E, Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL., 2016Journal Article, 2016
• Murray C, Quinn F, Illyes G, Walker J, Castriciano G, O'Sullivan P, Grant C, Vandenberghe E, Bird B, Flavin R, Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin Lymphoma., 2016Journal Article, 2016
• Haslam K, Langabeer SE, Hayat A, Conneally E, Vandenberghe E, Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia., 2016Journal Article, 2016
• Ryan C, Ged Y, Quinn F, Walker J, Kennedy J, Gillham C, Pittaluga S, McDermott R, Vandenberghe E, Grant C, Flavin R, Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant., 2016Journal Article, 2016
• McGovern B, Quinn F, Andrews C, Jeffers M, Bacon CL, Bird B, Crotty G, Vandenberghe E, Flavin R, NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia., 2016Journal Article, 2016
• O'Kane G, Bracken-Clarke D, Gardiner N, Lee G, Ni Chonghaile M, Power D, Daly PA, McCaffrey J, Bacon CL, Conneally E, Flynn C, Vandenberghe E, Kennedy MJ, Browne PV, O'Donnell DM, Hayden PJ, A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen., 2016Journal Article, 2016
• Marchand T, Lamy T, Finel H, Arcese W, Choquet S, Finke J, Huynh A, Irrera G, Karakasis D, Konopacki J, Lambert J, Michieli M, Schouten HC, Schroyens W, Sucak G, Tischer J, Vandenberghe E, Dreger P, Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation., 2016Journal Article, 2016
• Dowling AK, Liptrot SD, O'Brien D, Vandenberghe E, Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry., 2016Journal Article, 2016
• Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia., 2015Journal Article, 2015
• Maguire A, Castriciano G, Walker J, Molloy K, Quinn F, Osman N, Vandenberghe E, Jeffers M, Gaffney E, Flavin R, Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma., 2015Journal Article, 2015
• Cattaneo C, Finel H, McQuaker G, Vandenberghe E, Rossi G, Dreger P, Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European Society for Blood and Marrow Transplantation experience., 2015Journal Article, 2015
• Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise D, Milpied N, Sucak G, Sureda A, Thomson K, Vandenberghe E, Vitek A, Dreger P, Lymphoma Working Party of the EBMT, Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party., 2015Journal Article, 2015
• Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia., 2014Journal Article, 2014
• Liptrot S, O' Brien D, Langabeer SE, Quinn F, Mackarel AJ, Elder P, Vandenberghe E, Hayden PJ, An immunophenotypic and molecular diagnosis of composite hairy cell leukaemia and chronic lymphocytic leukaemia., 2013Journal Article, 2013
• Laura Christine Kickham, Anthony M McElligott, Adriele Prina-Mello, Elisabeth A Vandenberghe, Yuri Volkov, Paul Browne, Interrogating the Interaction of CD52 Functionalised Metallic Nanoparticles with Malignant B Lymphocytes , Blood, 126 , (23 ), 2015Journal Article, 2015, URL
• Elhassadi E, Flavin R, Browne P, Conneally E, Hayden P, Quinn F, Higgins E, Vandenberghe E, Transformed follicular lymphoma (tFL): consolidation therapy may improve survival, Irish Journal of Medical Science, 1863, 2017, p589-595Journal Article, 2017, DOI , URL
• Ghnewa YG, O'Reilly VP, Vandenberghe E, Browne PV, McElligott AM, Doherty DG, Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells, Clinical Immunology, 183, 2017, p91 - 98Journal Article, 2017, URL
• Kerim, S., Mecucci, C., Cuneo, A., Vandenberghe, E., Louwagie, A., Stul, M., Michaux, J.-L., Van Den Berghe, H., 5q - Anomaly in lymphoid disorders, Leukemia, 4, (1), 1990, p12-15Journal Article, 1990
• Avivi, I., Boumendil, A., Finel, H., Nagler, A., de Sousa, A.B., Santasusana, J.M.R., Vandenberghe, E., Afanasyev, B., Bordessoule, D., Moraleda, J.M., Garcia, E.C., Pohlreich, D., Garcia, G.G., Thomson, K., Or, R., Beelen, D., Zuffa, E., Giebel, S., Berthou, C., Salles, G., Melpignano, A., Montoto, S., Dreger, P., Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation, Bone Marrow Transplantation, 2018, p1-9Journal Article, 2018
• Frawley, T., O'Brien, C.P., Conneally, E., Vandenberghe, E., Percy, M., Langabeer, S.E., Haslam, K., Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms, Genetic Testing and Molecular Biomarkers, 22, (2), 2018, p98-103Journal Article, 2018
• Dreger, P., Michallet, M., Bosman, P., Dietrich, S., Sobh, M., Boumendil, A., Nagler, A., Scheid, C., Cornelissen, J., Niederwieser, D., Müller, L., Vandenberghe, E., Scortechini, I., Schoemans, H., Andersen, N.S., Finke, J., Russo, D., Ljungman, P., Passweg, J., van Gelder, M., Durakovic, N., Labussiere-Wallet, H., Berg, T., Wulf, G., Bethge, W., Bunjes, D., Stilgenbauer, S., Canepari, M.E., Schaap, M., Fox, C.P., Kröger, N., Montoto, S., Schetelig, J., Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties, Bone Marrow Transplantation, 2018, p1-9Journal Article, 2018
• Appleby, N., O"Brien, D., Quinn, F.M., Smyth, L., Kelly, J., Parker, I., Scott, K., Cahill, M.R., Crotty, G., Enright, H., Hennessy, B., Hodgson, A., Leahy, M., O"Leary, H., O"Dwyer, M., Hayat, A., Vandenberghe, E.A., Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL, Leukemia and Lymphoma, 59, (6), 2018, p1338-1347Journal Article, 2018
• Jones, J.A., Robak, T., Brown, J.R., Awan, F.T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I.W., Owen, C., Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial, The Lancet Haematology, 4, (3), 2017, pe114-e126Journal Article, 2017
• Eyre, T.A., Osborne, W.L., Gallop-Evans, E., Ardeshna, K.M., Kassam, S., Sadullah, S., Sidra, G., Culligan, D., Arumainathan, A., Shankara, P., Bowles, K.M., Eyre, D.W., Peng, Y.Y., Pettengell, R., Bloor, A., Vandenberghe, E., Collins, G.P., Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma, British Journal of Haematology, 2017Journal Article, 2017
• Vandenberghe, E., Primary gastrointestinal lymphomas, Experimental Oncology, 34, (4), 2012, p385-386Journal Article, 2012
• Hough, R.E., Wilson, G.A., Laidlaw, S.T., Suvarna, S.K., Vandenberghe, E.A., Primary follicular non-hodgkins lymphoma (NHL) of bone, Blood, 96, (11 PART II), 2000Journal Article, 2000
• Sarah Brophy , Fiona M Quinn, David O'Brien, Paul Browne, Elisabeth A. Vandenberghe , Anthony M. McElligott, The Regulation of STAT3 and Its Role in the Adhesion and Migration of Chronic Lymphocytic Leukaemia Cells, Blood, American Society of Hematology Annual Meeting, San Diego, CA, USA, 3-6, December, 201, 128, (22), American Society of Hematology, 2016, pp4347-Poster, 2016, URL
• Brophy S et al, Microenvironmental-Mediated Regulation of L-Selectin in Chronic Lymphocytic Leukaemia, Blood, American Society of Hematology Annual Meeting, Orlando, FL, USA, 5-8 December, 2015, 126, (23), American Society of Hematology, 2015, pp4133 - 4133Poster, 2015, URL
• Carmel Waldron,David O'Brien,Sarah Brophy,Kanthi Perera,Gerard M. Crotty,Eoghan Dunlea,Aileen Walsh,Michelle Connolly,Ruth Clifford,Hilary O'Leary,Ashique Khan,Greg Lee,Emer Atkinson,Giao Le,Alexander Gillett,Christopher L. Bacon,Anthony M. McElligott,Fiona Quinn,Elisabeth Vandenberghe, Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning, British Journal of Haematology, 2021Journal Article, 2021, DOI , URL , TARA - Full Text
• P McGettigan, EE Mooney, M Sinnott, EC Sweeney, J Feely, Sudden death in Whipple's disease, Postgraduate Medical Journal, (73), 1997, p509 - 511Journal Article, 1997
• Hayat A., O'Brien, D., O'Rourke P., McGuckin S., Fitzgerald S., Conneally E., Browne P., McCann S., Lawler M., Vandenberghe E.., CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia., Leukemia & Lymphoma, 47, (11), 2006, p2371 - 2379Journal Article, 2006
• Power M, Vandenberghe E, Browne PV, Kilmartin D, O'Connor M, Sheehy N, McCann S., Retinal and Cerebral Toxoplasmosis following Non-Myeloablative Stem Cell Transplant for Chronic Lymphocytic Leukaemia., Bone Marrow Transplantation, 36, (11), 2005, p735 - 736Journal Article, 2005
• Hayden PJ, Crampe M, Lawler M, Conneally E, McCann SR, Vandenberghe E, Browne PV., Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST., Bone Marrow Transplantation, 36, 2005, p735 - 736Journal Article, 2005
• Hayden PJ, O'Driscoll A, Gardiner N, Swords R, Sargent J, Ni Ainghle F, Fortune A, Murphy PT, Leahy M, Jackson F, Ryan M, Hennessy B, Cahill M, Crotty G, Enright H, Conneally E, Vandenberghe E, McCann SR and Browne PV. , Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003., Irish Journal of Medical Science, Apr-June 174, (2), 2005, p26 - 32Journal Article, 2005
• Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, O'Riordan J, Locasciulli A, Socié G, Kelly A, Schrezenmeier H, Marin P, Tichelli A, Passweg JR, Dickenson A, Ryan J, Bacigalupo A; Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group., Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA., British Journal of Haematology, 144, (6), 2009, p933-945Journal Article, 2009, DOI
• O'Donghaile D, Hayden PJ, McCarron SL, Doyle EM, Lawler M, Browne PV, Conneally E, Vandenberghe E, McCann SR., Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor., European Journal of Haematology, 76, (3), 2006, p258-260Journal Article, 2006, DOI
• Maginn EN, Browne PV, Hayden P, Vandenberghe E, McDonagh B, Evans P, Goodyer M, Tewari P, Campiani G, Butini S, Williams DC, Zisterer DM, Lawler MP, McElligott AM., PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells., British Journal of Cancer, 104, (2), 2011, p281 - 289Journal Article, 2011, DOI
• Langabeer SE, O'Brien D, Liptrot S, Flynn CM, Hayden PJ, Conneally E, Browne PV, Vandenberghe E, Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype., International Journal of laboratory Hematology, 34, (4), 2012, p417-21Journal Article, 2012
• Langabeer SE, Quinn F, O'Brien D, McElligott AM, Kelly J, Browne PV, Vandenberghe E, Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia., Leukemia research, 36, (4), 2012, p483-4Journal Article, 2012
• Haslam K, Chadwick N, Kelly J, Browne P, Vandenberghe E, Flynn C, Conneally E, Langabeer SE, Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemia., Irish journal of medical science, 179, (4), 2010, p507-10Journal Article, 2010
• Fortune AF, Kelly K, Sargent J, O'Brien D, Quinn F, Chadwick N, Flynn C, Conneally E, Browne P, Crotty GM, Thornton P, Vandenberghe E, Large granular lymphocyte leukemia: natural history and response to treatment., Leukemia & Lymphoma, 51, (5), 2010, p839 - 845Journal Article, 2010
• Hayat A, McGuckin S, Conneally E, Brown PV, McCann SR, Lawler M, Quinn F, Delaney E, O'Rourke P, Liptrot S, O'Brien D, Vandenberghe E, Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia., Irish journal of medical science, 178, (4), 2009, p441-6Journal Article, 2009
• Bacon CL, Daly P, Sheane B, Conneally EC, Browne PV, McCann S, Ni Chongaile M, O'Brian DS, Mc Dermott R, Hollywood D, Wilson L, Vandenberghe E, Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital., Irish medical journal, 102, (1), 2009, p26-8Journal Article, 2009
• Fahy CM, Fortune A, Quinn F, McMenamin ME, Browne PV, Langabeer S, McCarron S, Hayden P, Marren P, Ni Chonghaile M, Irvine AD, Vandenberghe E, Barnes L, Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia; transmission from allogeneic donor., The British journal of dermatology, 2013Journal Article, 2013
• Lyons J, Vandenberghe E, Fahy R, McDonnell C, Keane J, McLaughlin AM, An unusual lung mass post stem cell transplantation., Transplant infectious disease : an official journal of the Transplantation Society, 16, (4), 2014, p672-675Journal Article, 2014, DOI

• Title

  Prognostic Factors in Chronic Lymphocytic Leukaemia
  Summary

  Assessing the impact of immunophenotype, cytogenetic and molecular status on the clinical behaviour of the st James Hospital c Chronic Lymphocytic Leukaemia cohort
  Funding Agency

  Health Research Board
  Date From

  2002
  Date To

  2004
• Title

  TP53 mutation testing in CLL in Ireland: a template for the introduction of treatment defining molecular assays
  Summary

  Gilead UK and Ireland Fellow ship 2016 TP53 mutation testing in CLL in Ireland: a template for the introduction of treatment defining molecular assays
  Funding Agency

  Gilead
  Date From

  November 2016
  Date To

  April 2017
• Title

  The clinical implications of molecular analysis of coeliac disease, refractory celiac disease and enteropathy-associated T cell lymphoma (EATCL).
  Summary

  Analysis of the T cell receptor clonality status in duodenal biopsies and blood correlated with morphology and immunophenotype to determine the relationship between coeliac disease, refractory coeliac disease and enteropathy associated T cell lymphoma
  Funding Agency

  Bone Marrow for Leukaemia Trust
  Date From

  2006
  Date To

  2007
• Title

  Role of FISH analysis in Chronic Lymphocytic Leukaemia prognosis '
  Summary

  Fellowship, 2001 Principal Investigator E60, 000.00
  Funding Agency

  Bone Marrow for Leukaemia Trust
  Date From

  2001
  Date To

  2002

Oncology and cancer biology, Oncology and cancer biology, Genetics and Genomics, Oncology and cancer biology, Genetics and Genomics, Genetics and Genomics,

• Member of the Lymphoma Working Party of the European Blood and Marrow Transplant (EBMT) Group present
• Chairman of the lymphoma Forum Of Ireland present
• American Society of Haematology present
• Chairman of the haematology and lymphoma sub group of ICORG (Clinical Trials Ireland) 2009